⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesOTC Markets OTCQX

VRNO

Verano Holdings Corp.

Healthcare · Drug Manufacturers - Specialty & Generic

5.12USD

+0.1500 (+3.02%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on VRNO.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 5.12
P/E—
Dvd Ind Yld0.0%
P/B0.55
P/S0.4
Curr EV/T12M EBITDA4.5
Mkt Cap (USD)0.4B
Curr EV (USD)0.8B
2)

Per Share Data

EPS T12M-3.57
DPS0.00
Bk Val Per Sh9.24
Rev/Sh11.44
Cash/Sh1.16
Curr Shares Out73.2M
FCF/Sh0.63
3)

Cash Flow Analysis

P/CF4.2
Curr P/FCF8.2
CF/NI-0.3
Dvd P/O0.0%
Cash Gen/Cash Reqd2.0
Csh Dvd Cov—
CFO/Sales10.7%
Eff Interest Rate—
4)

Growth Potential

Dil EPS 1Y Gr27.6%
Cap 1Y Gr-19.2%
BPS 1Y Gr-28.4%
R&D To Sales—
Retention Rate100.0%
Rev 1Y Gr-6.5%
FCF 1Y Gr-11.5%
Assets 1Y Gr-12.7%
5)

Profitability

EBITDA-0.0B
EBIT-0.1B
Operating Margin-15.8%
Pretax Margin-24.5%
Net Margin-30.9%
ROA-14.2%
ROE-32.2%
ROC—
Asset Turnover0.46
6)

Structure

Current Ratio3.70
Quick Ratio1.31
Debt/Assets23.1%
Debt/Com Eq58.0%
Net Debt/EBITDA-24.46
Tot Debt/Capital36.7%
Gross Margin47.8%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.